Edamon™ Karamin raga na hannu Nebulizer mai ɗaukar hoto tare da Cire Mahimmancin Cordyceps
Edamon™ Karamin raga na hannu Nebulizer mai ɗaukar hoto tare da Cire Mahimmancin Cordyceps
$12.95 - $63.95
Edamon™ Karamin ragar Nebulizer na hannu mai ɗaukar hoto shine sabon nebulizer mai ɗaukar nauyi. Yana amfani da fasaha na nano-atomization don canza magungunan ruwa zuwa nau'i na ƙananan ƙwayoyin cuta. Lokacin amfani da Cordyceps Cire Fesa, ana iya shiga kai tsaye a cikin zurfin numfashi na numfashi, yana taimakawa magance cututtuka masu takurawa. da cututtuka masu hana numfashi (irin su asma, ciwon huhu, COPD, emphysema, mashako, fibrosis na huhu, da mashako), da kuma yana taimakawa hana sunadaran da ke haifar da ciwon iska. Ta yin wannan, za ku iya rage haushin hanyar iska da inganta aikin huhu gabaɗaya.
Umarnin Amfani:
Ƙungiyar Edamon ta yi amfani da fasahar cire ruwa mai zurfi don haɓaka haɓakar abubuwan da ke aiki kamar su cordycepic acid, cordycepin, da ergosterol a cikin Cordyceps Sinensis. Kowane Cordyceps Extract jigon daidai yake da gram 12 na sinadarai masu aiki na Cordyceps Sinensis.
Edamon™ Karamin raga na hannu Nebulizer ba kawai Nebulizer ba; yana wakiltar cikakkiyar daidaituwa tsakanin fasahar likitanci da buƙatu masu amfani. Falsafar ƙira ta musamman tana ba da babban inganci da buƙatun keɓantacce na marasa lafiya da ke sarrafa cututtukan numfashi. A cikin ci gaban wannan Nebulizer, an ba da fifiko ga ta'aziyyar haƙuri da jin daɗin mai amfani, yana ba masu amfani ƙwarewar jiyya na numfashi.
Gabatar da Edamon ™ Karamin raga na hannu Nebulizer mai ɗaukar hoto wani gagarumin ci gaba a fagen maganin tsarin numfashi, yana nuna sabon tunanin Cameron Derrington da kuma nuna jagorancin Mayo Clinic a cikin binciken likita da ƙirƙira fasaha. Wannan aikin haɗin gwiwar yana buɗe sabon babi a cikin maganin numfashi, yana ba da ƙarin ci gaba da mafita mai dacewa ga yawancin marasa lafiya.
Kunshin hada da: 1 x Edamon™ Nebulizer mai ɗaukuwa mai ƙaƙƙarfan raga na hannu tare da Mahimmancin Cire Cordyceps
Sharhi
Babu reviews yet.